Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent.

Blumberg DA, Pineda E, Cherry JD, Caruso A, Scott JV.

Am J Dis Child. 1992 Oct;146(10):1148-50.

PMID:
1415040
2.

Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group.

Blumberg DA, Mink CM, Cherry JD, Johnson C, Garber R, Plotkin SA, Watson B, Ballanco GA, Daum RS, Sullivan B, et al.

J Pediatr. 1991 Aug;119(2):194-204.

PMID:
1907317
3.

Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.

Marcinak JF, Ward M, Frank AL, Boyer KM, Froeschle JE, Hosbach PH 4th.

Am J Dis Child. 1993 Mar;147(3):290-4. Erratum in: Am J Dis Child 1993 Jun;147(6):626.

PMID:
8438810
4.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.

Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME.

Arch Pediatr Adolesc Med. 1994 May;148(5):503-7.

PMID:
8180641
5.

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.

Blumberg DA, Mink CM, Cherry JD, Reisinger KS, Blatter MM, Congeni BL, Dekker CL, Stout MG, Mezzatesta JR, Scott JV, et al.

J Pediatr. 1990 Jul;117(1 Pt 1):46-51.

PMID:
2196360
6.

Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.

Halperin SA, Barreto L, Friesen B, Meekison W.

Arch Pediatr Adolesc Med. 1994 May;148(5):495-502.

PMID:
7910089
7.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
8.
9.

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.

Huang LM, Lee CY, Lin TY, Chen JM, Lee PI, Hsu CY.

Vaccine. 1996 Jun;14(9):916-22.

PMID:
8843635
10.

Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.

Richie E, Punjabi NH, Harjanto SJ, Wangsasaputral F, Sukandar M, Supriatman M, Simanjuntak CH, Que JU, Cryz SJ Jr.

Vaccine. 1999 Mar 17;17(11-12):1384-93.

PMID:
10195774
11.

Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.

Bernstein HH, Rothstein EP, Pichichero ME, Francis AB, Kovel AJ, Disney FA, Green JL, Marsocci SM, Lynd AM, Wood GC, et al.

Am J Dis Child. 1992 May;146(5):556-9. Erratum in: Am J Dis Child 1992 Sep;146(9):1084. Am J Dis Child 1992 Jul;146(7):802.

PMID:
1621656
12.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group..

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
13.

Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.

Morgan CM, Blumberg DA, Cherry JD, Reisinger KS, Blatter MM, Blumer JL, Dekker CL, Stout MG, Christenson PD.

Am J Dis Child. 1990 Jan;144(1):41-5.

PMID:
2403747
14.

Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines.

Christy C, Pichichero ME, Reed GF, Decker MD, Anderson EL, Rennels MB, Englund JA, Edwards KM, Steinhoff MC.

Pediatrics. 1995 Sep;96(3 Pt 2):584-7.

PMID:
7659481
15.

Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany.

Heininger U, Cherry JD, Christenson PD, Eckhardt T, Göering U, Jakob P, Kasper W, Schweingel D, Laussucq S, Hackell JG, et al.

Vaccine. 1994 Jan;12(1):81-6.

PMID:
8303945
16.
17.

A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.

Steinhoff MC, Reed GF, Decker MD, Edwards KM, Englund JA, Pichichero ME, Rennels MB, Anderson EL, Deloria MA, Meade BD.

Pediatrics. 1995 Sep;96(3 Pt 2):567-70.

PMID:
7659477
18.

Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.

Auerbach BS, Lake AM, Wilson ME, Willingham FF, Shematek J, Moulton L, Deforest A, Halsey NA.

Biologicals. 1998 Jun;26(2):145-53.

PMID:
9811522
19.

Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.

Rothstein EP, Bernstein HH, Glode MP, Laussucq S, Nonenmacher J, Long SS, Hackell JG.

Am J Dis Child. 1993 Aug;147(8):854-7.

PMID:
8394646
20.

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SG.

J Pediatr. 1998 Jun;132(6):983-8.

PMID:
9627590

Supplemental Content

Support Center